Clinical study on Acupoint Application Therapy for simple obesity

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036847

Enrollment

Unknown

Registered

2020-08-25

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Experimental group:acupoint application

control:placebo plaster

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Between the ages of 18 and 60 years; Meet the diagnostic criteria of simple obesity; Willing to cooperate with the treatment protocol and sign the informed consent.

Exclusion criteria

Exclusion criteria: A pregnant or lactating woman; Acupoint application for the treatment of allergies; With serious complications such as heart, liver, kidney or brain; And other serious primary diseases; Psychopath.

Design outcomes

Primary

Measure	Time frame
BMI;abdominal girth;weight;weight;blood fat;subcutaneous fat;	—

Secondary

Measure	Time frame
triglyceride;cholesterol;HDL-C;LDL-C;	—

Countries

China

Contacts

Public ContactXu Ye

Longhua Hospital Affiliated to Shanghai University of traditional Chinese medicine

rebelleafxuye@hotmail.com+86 18916786212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026